Enlil Launches Governed AI for MedTech Regulation
CAMPBELL, Calif., August 18, 2026 Enlil, Inc. has introduced a four-layer governed AI architecture designed to help medical device...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CAMPBELL, Calif., August 18, 2026 Enlil, Inc. has introduced a four-layer governed AI architecture designed to help medical device...
LONDON, June 18, 2026 TrialAssure and Cancer Research UK’s Centre for Drug Development (CDD) have announced a strategic collaboration...
IRVINE, California, USA – June 8, 2026 Thirdwayv Inc. has highlighted the role of its advanced age-gating and authentication...
SAN FRANCISCO, Calif., Oct. 7, 2025 — Verana Health announced the expansion of its MIPS Advisory Services, offering enhanced...
